Company Name Date Type Amount Raised (Mil) Investors in round Stage at Funding Primary Therapeutic Area Primary Tech Article
Intact Vascular 5.29.19 Undisclosed $25.00 07 Device – Any Other Device (General) Link
Vesper Medical 5.29.19 Undisclosed $37.00 09 Not Disclosed Unknown Unknown
PhaseBio Pharmaceuticals Inc. 4.11.19 Common $43.00 04 Phase II Not Applicable Formulation – Other Link
Noveome Biotherapeutics Inc. 4.09.19 Series D $15.00 04 Phase II Dermatologic Small Molecule Link
PhaseBio Pharmaceuticals Inc. 3.25.19 Debt/Loan $7.50 04 Phase II Not Applicable Formulation- Other Link
Harmony Biosciences LLC 3.13.19 Debt/Loan $200.00 09 Not Disclosed Neurologic Other Tech
NeuBase Therapeutics Inc. (Ohr Pharmaceutical) 3.11.19 Common $9.00 09 Not Disclosed Neurologic Gene Therapy Link
Geneos Therapeutics Inc. 2.21.19 Series A $10.50 09 Not Disclosed Neurologic Gene Therapy Link
Passage Bio Inc. 2.14.19 Series A $115.50 OrbiMed Advisors LLC, Frazier Healthcare Partners, Versant Ventures, New Leaf Venture Partners, Vivo Capital LLC, Lilly Asia Ventures 09 Not Disclosed Neurologic Gene Therapy Link
Inovia Pharmaceuticals Inc. 2.13.19 Convertible Note $65.00 04 Phase II Infectious N/A Link
Trevena Inc. 1.30.19 Common $10.00 05 Phase IIII Neurologic Small Molecule Link
Aro Biotherapeutics Co. 12.11.18 Undisclosed $13.00 09 Not Disclosed Cancer Protein Link
Marinus Pharmaceuticals Inc. 12.11.18 Common $45.00 04 Phase II Neurologic Not Applicable Link
XyloCor Therapeutics Inc. 12.06.18 Series A $17.00 Sofinnova Ventures Inc. Life Sciences Partners 03 Phase I Cardiovascular Gene Therapy Link
Helius Medical Technologies 11.14.18 Common $17.50 07 Device – Any Neurologic Device (General)
Cabaletta Bio Inc. 11.08.18 Series A $38.50 5AM Ventures, Adage Capital Management L.P., University of Pennsylvania 02 Preclinical / IND Autoimmune Immunotherapy / Cell Therapy Link
Group K Diagnostics Inc. 10.31.18 Series A $2.00 07 Device – Any Not Applicable Device (General)
Aclaris Inc. 10.15.18 Debt / Loan $30.00 Oxford Finance LLC 05 Phase III Dermatologic Small Molecule Link
PhaseBio Pharmaceuticals Inc. 09.21.18 IPO $46.00 04 Phase II Not Applicable Formulation – Other Link
Galera Therapeutics Inc. 09.19.18 Series C $70.00 Clarus Ventures LLC, Adage Capital Management L.P., HBM Healthcare Investments Ltd., Nan Fung Life Sciences, RA Capital Management LLC, Rock Springs Capital LP, Tekla Capital Management (formerly H&Q Capital Management), Correlation Ventures, Galera Angels, New Enterprise Associates, Novartis Venture Fund, Novo Ventures (Novo Holdings A/S), Sofinnova Ventures Inc. 04 Phase II Cancer Small Molecule Link
PhaseBio Pharmaceuticals Inc. 09.05.18 Series D $34.00 Cormorant Asset Management LLC, Rock Springs Capital LP, Mountain Group Capital, New Enterprise Associates, Hatteras Venture Partners, AstraZeneca plc, Johnson & Johnson Innovation – JJDC Inc., Syno Capital, Fletcher Spaght Ventures 04 Phase II Not Applicable Small Molecule Link
Aevi Genomic Medicine Inc. 08.21.18 Common $4.90 04 Phase II Neurologic Small Molecule Link
Krystal Biotech 08.16.18 Common $10.00 Frazier Healthcare Partners 09 Not Disclosed Unknown Unknown Link
Fibrocell Science Inc. 07.02.18 Common $3.96 06 Approved Not Applicable Immunotherapy / Cell Therapy
Carisma Therapeutics Inc. 06.27.18 Series A $53.00 AbbVie Ventures, HealthCap, IP Group plc, University of Pennsylvania, Grazia Equity, Wellington Partners, TPG, MRL Ventures Fund LLC, Agent Capital 02 Preclinical / IND Cancer Immunotherapy / Cell Therapy Link
Neuronetics Inc. 05.31.18 IPO $107.50 07 Device – Any Neurologic Device (General) Link
Fibrocell Science Inc. 05.29.18 Common $5.80 06 Approved Not Applicable Immunotherapy / Cell Therapy
Hemispherx Biopharma Inc. 04.20.18 Undisclosed Undisclosed 06 Approved Infectious Small Molecule
Carisma Therapeutics Inc. 04.17.18 Debt / Loan $3.85 01 Platform / Discovery Cancer Immunotherapy / Cell Therapy
TELA Bio Inc. 04.17.18 Undisclosed Undisclosed Checkmate Capital 07 Device – Any Gastrointestinal Device (General) Link
Intact Vascular Inc. 04.16.18 Series C $20.00 New Enterprise Associates, H.I.G. BioVentures, Quaker Partners 07 Device – Any Other Device (General) Link
Windtree Therapeutics Inc. 04.04.18 Common $2.60 07 Device – Any Pulmonary Device (General) Link
Helius Medical Technologies Inc. 04.04.18 Common $18.40 07 Device – Any Neurologic Device (General) Link
STRATA Skin Sciences Inc. 04.02.18 Common $17.00 Broadfin Capital, Sabby Management 07 Device – Any Dermatologic Device (General) Link
Tmunity Therapeutics Inc. 01.23.18 Series A $100.00 Ping An Ventures, Parker Institute for Cancer Immunotherapy, Gilead Sciences Inc., Be The Match (National Marrow Donor Program), University of Pennsylvania, Lilly Asia Ventures 01 Platform / Discovery Cancer Immunotherapy / Cell Therapy) Link
Strongbridge Biopharma Plc 01.23.18 Common $35.47 05 Phase III Endocrine / Metabolic Small Molecule
OptiNose Inc. 01.02.18 Convertible Notes $75.00 Athyrium Capital Management 06 Approved Pulmonary Small Molecule